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Abstract
This prospective Irish observational study examined maternal and infant nutritional supplement use. From an initial sample of 539
mothers recruited from the Coombe Women and Infants University Hospital in Dublin (during 2004-2006), 450 eligible mothers were
followed up at 6 weeks and 6 months postpartum. Only 200 women (44.4%) complied with peri-conceptional folic acid at the
recommended time with strong social patterning associated with its uptake. Almost 10% of the sample (n=44) consumed a
combined multivitamin and mineral supplement during pregnancy. A vitamin D-containing supplement was provided to only 5 (1.1%)
and 15 (3.3%) infants at 6 weeks and 6 months, respectively. A national guideline that advises on adequate and safe use of both
vitamin and multivitamin supplements during pregnancy with particular reference to vitamin A and D is warranted. Given the
re-emergence of rickets in Ireland, and the reported morbidities associated with vitamin D insufficiency, promoting and monitoring
compliance with 200IU [5μg] daily vitamin D supplements to all infants particularly those from higher risk groups from birth to 1 year,
should be a public health priority.
Introduction
Consumption of nutritional supplements can play an important role
in achieving recommended dietary intakes1, particularly in highrisk populations2. Since peri-conceptional folic acid (FA)
supplementation has been shown to decrease the incidence1 and
recurrence3 of neural tube defects (NTDs), policy in Ireland
recommends that women consume a daily 400μg FA supplement
for a minimum of 12 weeks pre-conceptionally until the 12th
week of pregnancy, in addition to a folate-rich diet4. More recently,
considerable attention has been given to the adverse skeletal and
non-skeletal clinical outcomes associated with vitamin D
insufficiency5, including increased risks of pre-eclampsia, calcium
malabsorption and higher parathyroid hormone levels in pregnant
women6, as well as hypocalcaemic seizures, skeletal deformity,
fractures, rickets, cardiomyopathy and growth failure in infants7,8.

High rates of vitamin D insufficiency during pregnancy (5-50%)
and infancy (10-56%)6,8,9 and childhood nutritional rickets are
increasingly being reported. Sub-optimal vitamin D status is
attributed to an inadequate dietary intake9,10 and poor dermal
synthesis due to sunscreen use, dark skin pigmentation, extensive
clothing cover, limited sunlight exposure especially from October
to March at northerly latitudes >~35º2,11. Infants are at an
additional risk if they are born to mothers with low vitamin D
status12. Recognising these concerns, recent Irish policy in 2010
recommends a 200IU [5μg] vitamin D daily supplement for all
infants from birth to 1 year13.
However, high-dose supplementation at levels in excess of
tolerable upper limits can be hazardous to health. Preformed
vitamin A-containing supplements in daily doses ≥ 10,000 IU are
teratogenic14, and consumption of vitamin C and E supplements

Irish Medical Journal June 2011 Volume 104 Number 6 www.imj.ie

Original Paper

174

Original Paper

Table 1 Baseline characteristics of the total sample
(n=450), and by nationality

Characteristic

Maternal age
(years) (mean ± SD)

Total
sample
(n=450)
n (%)

Irish
National
Mothers*
(n=401)
n (%)

Non-Irish
National
Mothers†
(n=49)
n (%)

29.2 ± 5.7

29.1 ± 5.8

30.18 ±
5.48

Maternal education level

Variable

Supplements
Folic acid
other than
uptake at the
folic acid and
recommended
iron during
time
pregnancy*
(n=200)
(n=48)
n (%)
n (%)

Maternal age (years)
< 24

(6)†

Primary/secondary

(39.3)

(39.9)

(34.7)

24-34

134

Vocational/training
course

(27.6)

(28.7)

(18.4)

> 34

54

Third level degree/
postgraduate level

Married/cohabitating
Single

(31.4) 23

(46.9)

(90.4)
43

(9.6)

(89.5)
42

(10.5)

48 (97.9)
1

(2)

No

(10.4)

(67)

34

(70.8)

(27)

9

(18.8)

(20.9)

Primary/secondary

7

(14.6)†

(26)†

Vocational/training course

63

(31.5)

(20.8)

Third level degree/
postgraduate level

85

(42.5)

31

(64.6)

198

(99)†

47

(97.9)

1

(2.1)

4

(8.3)‡

Marital status

Smoking during pregnancy
Yes

5

Maternal education level
149 (33.1) 126

Marital status
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Table 2 Factors associated with maternal nutritional
supplementation practices during pregnancy

(23.2)‡

356 (79.1) 308 (76.8)

(2)‡
48 (97.9)

Married/cohabitating
Single

2

(1)

Smoking during pregnancy

Planned current pregnancy
Yes

282 (62.7) 250 (62.3)

32

(65.3)

No

168 (37.3) 151 (37.7)

17

(34.7)

Infant birth weight
3.55 ±0.52 3.55 ± 0.52 3.59 ± 0.54
(kg) (mean ± SD)
Initiated breastfeeding postpartum
Yes

228 (50.7) 189 (47.1)‡ 39 (79.6)‡

No

222 (49.3) 212 (52.9)

10

(20.4)

SD, standard deviation. *All mothers were white Caucasian; †Racial groups
include: white Caucasian (51%), Black African (37%), Asian (10%) and
American Indian (2%); ‡ P<0.001: differences between Irish national and
non-Irish national mothers.

during pregnancy have been associated with lower birth weight15.
However, there is no Irish policy on the recommended use or dose
of these or other vitamins in pregnancy and data on prevalence of
their use is scant. Furthermore, in light of the recent vitamin D
supplementation policy for all infants, it is important to understand
current supplementation patterns. This study was designed to
examine the prevalence of maternal and infant nutritional
supplementation practices; a second objective was to determine
the factors associated with maternal nutritional supplement use
during pregnancy.
Methods
The methods and sample representativeness of this prospective
observational study are already reported in detail16. In summary,
491/539 (91%) women from antenatal clinics in the Coombe
Women and Infants University Hospital (CWIUH) during June
2004-October 2006 agreed to participate. 450 mothers (401
Irish national [Irish-born] and 49 non-Irish national [non-Irishborn]) meeting study criteria and delivering a healthy full term
singleton infant were followed up at 6 weeks and 6 months
postpartum. The antenatal patient-administered survey addressed
pregnancy supplement use (type, brand and dose) and initiation

Yes
No

(9)†
182

(91)

44

(91.7)

Yes

186

(93)†

32

(66.7)

No

14

(7)

16

(33.3)

Planned current pregnancy

*Supplements include: combined multivitamin and mineral (n=44), omega3 fish oil (n=7) and vitamin D (n=5). †P<0.001; ‡P<0.05: significant
differences between the groups within the columns.

time, socio-demographic factors and pregnancy smoking habit.
The maternal, obstetric and infant characteristics and the timing of
FA supplementation were extracted from the mother’s and/or
infant’s medical notes, and any self-reporting ambiguity clarified.
The 6 week and 6 month postpartum interviewer-administered
surveys elicited information on maternal and infant supplement
use (type, brand and dose).
The Statistical Package for the Social Sciences (SPSS®, version
17) was used to analyse the data. Comparison between groups
was performed using the Student’s t-test for continuous variables,
and the Chi-square test or Fishers exact test for categorical
variables. Descriptive results are expressed as percentages (%),
means and standard deviations (SD), and median with interquartile
ranges (IQR), as appropriate. Binary logistic regression analysis
was used to determine the factors associated with maternal
nutritional supplement use during pregnancy. Ethical approval was
granted by the Ethical Committees of the CWIUH and Dublin
Institute of Technology.
Results
Data for the 450 mother-infant pairs (n=401 Irish national; 49
non-Irish national) were complete. The mean age of mothers at
antenatal recruitment (median 36 weeks gestation, IQR: 32-39
weeks) was 29.2 years (SD 5.7) (Table 1). Significantly fewer nonIrish national compared with Irish national mothers smoked during
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Figure 1 Maternal nutritional supplementation practices during
pregnancy (n=450)

In the univariate analysis (Table 2), education to third level
degree/postgraduate compared with primary/secondary level was
significantly associated with both use of FA at the recommended
pregnancy (2% vs 23.2%, P=0.000) and their breastfeeding
time (42.5% vs 26%, P=0.000), and other nutritional supplements
initiation rates were higher (79.6% vs 47.1%, P=0.000).
during pregnancy including, multivitamin and mineral, omega-3
fish oil and vitamin D (64.6% vs 14.6%, P=0.000). Factors
Maternal vitamin and mineral supplementation practices during
positively associated with combined multivitamin and mineral
pregnancy
and/or vitamin D and/or omega-3 fish oil supplement use during
Although 395/450 women (87.7%) reported to taking a specific
pregnancy, after adjustment, included breastfeeding initiation,
peri-conceptional FA supplement, only 200 women (44.4%)
maternal nutritional supplement use at 6 weeks postpartum and
commenced FA at the recommended time i.e. either
education to third level degree/postgraduate
(Table 3).
Table 3 Factors associated with maternal consumption of a combined
Maternal supplementation practices postpartum
multivitamin and mineral and/or vitamin D and/or omega-3
At 6 weeks postpartum (median 6.5 weeks, IQR
fish oil supplement during pregnancy (n=48): binary logistic
6.1-7 weeks) 206/450 mothers (45.7%)
regression model
consumed a nutritional supplement. These
included iron (n=153, 74%) and a combined
multivitamin and mineral supplement (n=74,
Independent
35.9%). Other supplements consumed included,
Estimates
SE
df
P
OR (95%CI)
variables
evening primrose oil (n=6), omega-3 fish oil
(n=5), calcium (n=2), vitamin B-Complex (n=2),
probiotic (n=1) and FA (n=1).
Breastfeeding initiation postpartum
Infant supplementation practices
No*
1.428
0.448
1
0.001
4.17 (1.73-10)
At 6 weeks postpartum, 6 infants (1.3%)
received at least one nutritional supplement
Yes
daily. These included a vitamin A, B, C and Dcontaining supplement (n=4), vitamin D only
Maternal nutritional supplement use at 6 weeks postpartum†
(n=1), vitamin C (n=1) and fluoride (n=1). At 6
No*
1.307
0.357
1
0.000
3.69 (1.83-7.44)
months postpartum (median 24.7 weeks IQR
24.4-25 weeks), 17 infants (3.8%) consumed at
Yes
least one nutritional supplement daily, including
a vitamin A, B, C and D-containing supplement
Maternal education level
(n=12), vitamin D only (n=3), iron (n=1),
Primary/secondary
omega-3 fish oil (n=1) and fluoride (n=1). Two
level*
infants were given camomile drops, while
homeopathic drops (sulphur) were given to one
Third level degree/
1.209
0.496
1
0.015
3.34 (1.26-8.8)
infant for the treatment of eczema (data not
postgraduate level
shown).
Vocational/training
0.462
0.533
1
0.386 1.58 (0.55-4.51)
Discussion
course
A high prevalence of nutritional supplementation
SE, standard error; df, degrees of freedom; OR, odds ratio; CI, confidence interval.
was observed among both Irish, and non-Irish
Model controls for maternal age and smoking status during pregnancy.
national pregnant women in this study. Although
*Reference category; †Supplements include: combined multivitamin and mineral (n=74),
87.7% of the sample reported to taking a specific
evening primrose oil (n=6), omega-3 fish oil (n=5), calcium (n=2), vitamin B-Complex (n=2), FA supplement during pregnancy, only 44.4% of
probiotic (n=1) and folic acid (n=1).

Irish Medical Journal June 2011 Volume 104 Number 6 www.imj.ie

pre-conceptionally (n=181, 40.2%), or during
the first month post-conception (n=19, 4.2%). In
all, 160/450 women (35.5%) commenced
supplemental FA during the second month of
pregnancy, 35/450 (7.7%) during the third
month of pregnancy, while 55/450 women
(12.2%) did not take any FA. Uptake of FA at
the recommended time did not differ between
the Irish and non-Irish national populations
(44.6% vs 42.9%, P=0.933). Iron supplements
were consumed by 295/450 women (65.5%)
during pregnancy (Figure 1), with a high usage
observed during the first (n=132; 44.7%) and
second (n=136; 46.1%) trimesters of
pregnancy. A significantly greater proportion of
Irish, compared with non-Irish nationals reported
taking an iron supplement at any pregnancy
stage (67.3% vs 51%, P=0.035). In total,
48/450 women (10.6%) reported taking
nutritional supplements other than FA or iron,
including a combined multivitamin and mineral
(n=44), omega-3 fish oil (n=7) and vitamin D
(n=5).
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women commenced FA at the recommended time periconceptionally. In contrast to the higher peri-conceptional use of
FA among Irish nationals reported in a previous Dublin-based
study17, no nationality uptake difference was observed in our
study (44.6% vs 42.9%, respectively: P=0.933). In agreement
with the literature17,18, strong social patterning: marriage (99%),
third level degree/postgraduate (42.5%), non-smoking (91%) and
report of planned pregnancy (93%) were all associated with FA
uptake at the recommended time. Since neural tube closure
occurs between 22 and 28 days post conception19, the timing of
FA was suboptimal in over half of our sample of women (55.5%).
A slightly higher pre-conceptional FA rate of 45% is reported in a
previous Irish study18 than what we found (40.2%). Nonetheless,
to date, no Irish study has reported peri-conceptional FA rates
greater than 50% indicating that risk minimisation is not being
achieved. This warrants public health attention given that Irish
NTD rates are still among the highest in Europe (1-1.5 per 1000
total births nationally20). More effective public health efforts and
FA promotional campaigns are necessary to convince all women
of child-bearing age in Ireland of the critical time-frame for NTD
prevention.
Over 10% of the women in this study consumed a combined
multivitamin and mineral and/or omega-3 fish oil and/or vitamin D
supplement during pregnancy, with strong social patterning
associated with their use. Given the reported teratogenicity
associated with excessive supplemental vitamin A consumption
during pregnancy14, recommendations in the UK advise the
avoidance of vitamin A-containing supplements, including
multivitamins and fish liver oils, in addition to foods high in vitamin
A such as liver and pâté, during pregnancy21. However, such
recommendations for pregnant women in Ireland are lacking. To
prevent any potential teratogenic risks associated with excessive
vitamin A consumption, the establishment of a national
recommendation that provides guidelines on appropriate and safe
use of such supplements during pregnancy is warranted. Since
low maternal vitamin D status during pregnancy increases the
risks of vitamin D insufficiency and rickets in infants22, the
implementation of a national recommendation on vitamin D
pregnancy supplementation also needs to be addressed.
The incidence of rickets has risen in infants and toddlers in Ireland
and other developed countries over the past decade7,23,24. As
Ireland is located at 51o to 55o North, little or no vitamin D can be
produced from sunlight during the winter months. Although
exclusively breastfed infants and those with dark skin
pigmentation have been identified as particular high-risk groups
for vitamin D deficiency, all infants are at potential risk since their
vitamin D stores at birth are dependent on their mother’s vitamin D
status8, which is frequently insufficient according to recent
evidence. According to Muldowney25 (n=264 women; >95%
white-skinned: 2004-2006), 19% and 70% of pregnant women
living in Cork had serum 25(OH)D levels < 25 nmol/L and < 50
nmol/L, respectively, highlighting the high prevalence of vitamin D
insufficiency in pregnant women in Ireland. Findings from the
present study, conducted pre-HSE vitamin D recommendation
(2004-2006), indicate that only 5 infants at 6 weeks (1.1%) and
15 infants at 6 months (3.3%) were provided with a daily vitamin
D-containing supplement. To ensure an adequate infancy vitamin
D status the HSE recently recommended the provision of 200IU
[5μg] vitamin D per day to all infants from birth to 1 year13. Given
the potential for serious short and long term morbidities
associated with vitamin D insufficiency, health professionals in
Ireland should ensure that all parents, particularly those from atrisk populations, are aware of the HSE vitamin D recommendation.
In conclusion, a national health promotion campaign to advise
women on safe and effective nutrient supplementation during
pregnancy is required. Achieving compliance with infancy vitamin
D supplementation from birth to 1 year should be a public health
priority.
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